This HTML5 document contains 201 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n9http://dx.doi.org/10.1378/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q33637609
rdf:type
wikibase:Item
schema:description
vedecký článok artigo científico (publicado na 2009) artículo científico publicado en 2009 2009年论文 scienca artikolo 2009年論文 บทความทางวิทยาศาสตร์ سائنسی مضمون vědecký článek scientific article naučni članak vetenskaplig artikel wetenschappelijk artikel article scientifique (publié 2009) bài báo khoa học 2009年论文 مقالة علمية ২০০৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2009年論文 artigo científico 2009 թվականի մայիսին հրատարակված գիտական հոդված teaduslik artikkel мақолаи илмӣ articolo scientifico artículu científicu espublizáu en 2009 2009 թուականի Մայիսին հրատարակուած գիտական յօդուած 2009年论文 مقالهٔ علمی wissenschaftlicher Artikel 2009年の論文 2009년 논문 научна статия tieteellinen artikkeli article científic 2009年論文 artikull shkencor מאמר מדעי 2009 nî lūn-bûn vitskapeleg artikkel 2009年论文 articol științific научни чланак 2009年論文 tudományos cikk mokslinis straipsnis επιστημονικό άρθρο article scientific научни чланак bilimsel makale 2009年论文 vitenskapelig artikkel наукова стаття, опублікована в травні 2009 мақолаи илмӣ videnskabelig artikel (udgivet 2009) 2009年論文 artigo científico (publicado na 2009) научная статья artykuł naukowy სამეცნიერო სტატია 2009年论文 artikulong pang-agham
p:P577
wds:Q33637609-C37E6FAE-A2DC-4D46-BB86-B14BD4764D19
wdt:P577
2009-05-01T00:00:00Z
p:P407
wds:Q33637609-762A3EAE-30C2-49CA-96B6-CBA4668F043B
wdt:P407
wd:Q1860
p:P2860
wds:Q33637609-CCD3F5D7-0036-4BA5-829D-ACECE7528BB9 wds:Q33637609-D445D6EC-2FED-428A-9C34-3A35D3D4FFAB wds:Q33637609-D6587A5E-3C24-40DA-A109-ABF3DB5D17D5 wds:Q33637609-DC572DD8-3BFB-4522-924F-4F19291F9678 wds:Q33637609-E435F067-D1A8-4DA8-95CC-65E68D87FFCE wds:Q33637609-EC7D7B8B-AB48-4FA9-9553-D9102149296F wds:Q33637609-F514934A-4B66-4DEE-B8E5-68E88262D651 wds:Q33637609-F645FF9C-A0BD-464D-8F58-03ED8A4BBF1F wds:Q33637609-175152E5-1589-447E-AB2D-C84D4F7F173F wds:Q33637609-1D10A788-78FA-482A-AE2F-233EDACBC4B7 wds:Q33637609-2324AFA6-03D8-4221-9FFB-26416B95F9BD wds:Q33637609-2535B527-AC32-4518-9782-8684EC3281EA wds:Q33637609-27EE72BE-45C2-4A1D-8884-7F3053990BF1 wds:Q33637609-30394F70-44C1-4828-8D30-3B981E8D2ED2 wds:Q33637609-34F3E857-E9CD-4172-A815-89779A2AB9F1 wds:Q33637609-3ECAC7D5-369B-4E1A-A0C3-56C309408463 wds:Q33637609-40DA3DC1-3D97-4762-BFDB-5EB619F3FBE6 wds:Q33637609-46218714-6660-4E34-9C20-5896E0FD6CE6 wds:Q33637609-00CD01D9-DD96-4964-93B8-F5CE80224176 wds:Q33637609-0136D0C0-2933-4477-906D-9C6DC3750428 wds:Q33637609-909D0761-32B4-4667-B88B-757199F87A93 wds:Q33637609-956B2F08-619D-43EA-BEFC-94F4C0FAD846 wds:Q33637609-95B988F1-8F50-44EA-ABBA-42E8E4712354 wds:Q33637609-96496758-B724-4BC2-BE2E-FB1EDD91E6C8 wds:Q33637609-966503F0-B856-4A0D-8B80-D7DC47F6D87C wds:Q33637609-97C7A090-A4C8-4F31-ACD7-EF5C0BC05A03 wds:Q33637609-9CB7C50B-3D2D-428D-BC0F-3C65A99B4587 wds:Q33637609-A2326FF6-3659-4180-9F94-6BA72726978C wds:Q33637609-A6B32154-E893-419E-9E3A-5BE35D26CA79 wds:Q33637609-AD2E20E2-3209-40A0-877E-485F358620D2 wds:Q33637609-B12EB1D4-C280-4828-9911-96EB61114426 wds:Q33637609-B33DBE03-5F28-4BDE-BFC8-0F6F91BF6224 wds:Q33637609-B8AFCCBB-2778-4975-A678-EB90F09B6329 wds:Q33637609-C0A10D4F-272B-4E29-BD99-3F42495D5DE4 wds:Q33637609-5202BDA8-4C77-4646-8411-3E8AB5AA801A wds:Q33637609-52B733DB-DF38-4F92-AAAE-579BA8AA5DB4 wds:Q33637609-5AF67357-D6B4-4B9C-BE82-B8C946BC4A13 wds:Q33637609-5F218542-C41C-4014-9A39-DAAEE938D866 wds:Q33637609-62400FC9-785B-466E-AA16-BC41BB055BA0 wds:Q33637609-71219191-3969-4ED4-A32C-EED16BE5A2BB wds:Q33637609-74F6F26F-0FE6-4ABB-A79F-8094522AF53F wds:Q33637609-7E0F3FB9-5953-46DF-99BD-2E31BE354A30 wds:Q33637609-7F4DF3BD-4871-4E4E-BC76-395AACF21490 wds:Q33637609-8F674B79-6F41-445E-A958-6711A68A3512 wds:Q33637609-8FCC6615-8821-4EFF-A578-678D15BB65EC
wdt:P2860
wd:Q69396179 wd:Q34311841 wd:Q51668974 wd:Q37073953 wd:Q44666258 wd:Q77863770 wd:Q34991895 wd:Q36705687 wd:Q41027334 wd:Q30598221 wd:Q68246748 wd:Q29617876 wd:Q67682710 wd:Q71668843 wd:Q48032485 wd:Q70510071 wd:Q42038581 wd:Q35855126 wd:Q54767271 wd:Q71049425 wd:Q79975149 wd:Q35832601 wd:Q39605675 wd:Q37815158 wd:Q40816694 wd:Q73730784 wd:Q35980338 wd:Q35101932 wd:Q57099924 wd:Q36565892 wd:Q40498147 wd:Q77186328 wd:Q72043078 wd:Q35801043 wd:Q41965918 wd:Q33991760 wd:Q74713538 wd:Q81628285 wd:Q46971642 wd:Q39810272 wd:Q39356753 wd:Q71435944 wd:Q44216708 wd:Q64127265 wd:Q36645160
p:P2093
wds:Q33637609-92A870A8-8A51-4D61-AB2D-1164D86040F0 wds:Q33637609-AFA7A7F9-C6EB-4CC8-A48E-CC1E35C88A20 wds:Q33637609-372BF93A-F3A4-476B-8432-A5D03260B271 wds:Q33637609-FC6E6EAA-982D-47DB-AE43-446E66888646
wdt:P2093
Uzma A Khan Michelle N Gong Ednan K Bajwa B Taylor Thompson
rdfs:label
Plasma C-reactive protein levels are associated with improved outcome in ARDS. Plasma C-reactive protein levels are associated with improved outcome in ARDS. Plasma C-reactive protein levels are associated with improved outcome in ARDS.
skos:prefLabel
Plasma C-reactive protein levels are associated with improved outcome in ARDS. Plasma C-reactive protein levels are associated with improved outcome in ARDS. Plasma C-reactive protein levels are associated with improved outcome in ARDS.
schema:name
Plasma C-reactive protein levels are associated with improved outcome in ARDS. Plasma C-reactive protein levels are associated with improved outcome in ARDS. Plasma C-reactive protein levels are associated with improved outcome in ARDS.
p:P50
wds:Q33637609-339043DD-468A-4F94-AC25-3B4092778B6B wds:Q33637609-FD585C19-C73C-4B5D-9573-83FDA573C30F
wdt:P50
wd:Q63144011 wd:Q30069760
p:P1476
wds:Q33637609-23EF9DEA-4195-4BEA-9605-F6B44D09A57C
wdt:P1476
Plasma C-reactive protein levels are associated with improved outcome in ARDS.
p:P304
wds:Q33637609-4FD3AB5F-CA21-4024-A002-8F4BAF529833
wdt:P304
471-480
p:P31
wds:Q33637609-D24DF930-9EF2-42E9-970A-B4911F0E59E2
wdt:P31
wd:Q13442814
p:P921
wds:Q33637609-01718663-4BFE-4447-9920-0A92152D0D02
wdt:P921
wd:Q344873
p:P698
wds:Q33637609-C29A1DAF-6E30-43C8-8CDC-A974004F79CC
wdtn:P698
n8:19411291
wdt:P698
19411291
p:P1433
wds:Q33637609-13009E25-9079-4A63-BD32-E4B9B793B994
wdt:P1433
wd:Q5093377
p:P433
wds:Q33637609-0C200557-CF0C-4087-8F05-992526B31392
p:P478
wds:Q33637609-8A29919B-7729-4BF9-9F2D-26852BD4F7DD
wdt:P433
2
wdt:P478
136
p:P356
wds:Q33637609-2940D6F9-42AD-432D-8625-492808E2FCCE
wdtn:P356
n9:CHEST.08-2413
wdt:P356
10.1378/CHEST.08-2413
p:P5875
wds:Q33637609-79C65393-4390-408C-8185-1A3201B38BB4
wdt:P5875
24397859
p:P932
wds:Q33637609-551F40CA-F167-4543-B4CE-50BBA48751B6
wdt:P932
2818414